Role of Combining Anticoagulant and Antiplatelet Agents in COVID-19 Treatment: A Rapid Review

Kamal Matli, Raymond Farah, Mario Maalouf, Christy Costanian, Nibal Chamoun, Georges Ghanem
doi: https://doi.org/10.1101/2021.03.21.21253754

Article Information

doi 
https://doi.org/10.1101/2021.03.21.21253754
History 
  • March 22, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Kamal Matli, MD1,
  2. Raymond Farah, MSc2,
  3. Mario Maalouf, BSc3,
  4. Christy Costanian, PhD3,*,
  5. Nibal Chamoun, PharmD4 and
  6. Georges Ghanem, MD1,3,*
  1. 1Division of Cardiology, Department of Internal Medicine, LAU Medical Center-Rizk Hospital (LAUMC-RH), Beirut, Lebanon
  2. 2Lebanese University, Neuroscience Research Centre, Hadath, Lebanon
  3. 3School of Medicine, Lebanese American University (LAU), Byblos, Lebanon
  4. 4School of Pharmacy, Lebanese American University (LAU), Byblos, Lebanon
  1. ↵*corresponding authors: christy.costanian{at}lau.edu.lb; georges.ghanem{at}lau.edu.lb
Back to top
Posted March 22, 2021.
Download PDF
Data/Code
Email
Role of Combining Anticoagulant and Antiplatelet Agents in COVID-19 Treatment: A Rapid Review
Kamal Matli, Raymond Farah, Mario Maalouf, Christy Costanian, Nibal Chamoun, Georges Ghanem
medRxiv 2021.03.21.21253754; doi: https://doi.org/10.1101/2021.03.21.21253754
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area